Mifepristone may inhibit the midcycle gonadotropin surge at both ovarian and pituitary sites of action

Fertility and Sterility

Volumn 84, Issue 5, 2005, Pages 1545-1546

  Heikinheimo, Oskari ^a   Leminen, Riikka ^a   Raivio, Taneli ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GONADOTROPIN; INHIBIN B; MIFEPRISTONE;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN RELEASE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OVULATION INHIBITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

FEMALE; FOLLICULAR PHASE; GONADOTROPINS; HUMANS; MIFEPRISTONE; OVARY; PITUITARY GLAND;

EID: 27644479735     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.04.058     Document Type: Article

References (11)

1. L. Marions, K. Hultenby, I. Lindell, X. Sun, B. Ståbi, K. Gemzell Danielsson Emergency contraception with mifepristone and levonorgestrel mechanism of action Obstet Gynecol 100 2002 65 70
2. R. Leminen, T. Raivio, S. Ranta, J. Oehler, H. von Hertzen, A.O. Jänne Late follicular phase administration of mifepristone suppresses circulating leptin and follicle-stimulating hormone - mechanism(s) of action in emergency contraception? Eur J Endocrinol 152 2005 411 418
3. H. von Herzen, G. Piaggio, J. Ding, J. Chen, S. Song, G. Bartfai Low dose mifepristone and two regimens of levonorgestrel for emergency contraception a WHO multicentre randomised trial Lancet 360 2002 1803 1810
4. E. Escudero, P. Boerrigter, H. Coelingh Bennink, R. Epifanio, J. Horcajadas, F. Olivennes Mifepristone is an effective oral alternative for the prevention of premature LH surges and/or premature luteinization in women undergoing controlled ovarian hyperstimulation for in vitro fertilization J Clin Endocrinol Metab 90 2005 2081 2088
5. D. Baird, K. Thong, C. Hall, S. Cameron Failure of oestrogen-induced luteinizing hormone surge in women treated with mifepristone (RU 486) every day for 30 days Hum Reprod 10 1995 2270 2276
6. H. Croxatto, A. Salvatierra, B. Fuentealba, L. Leiva Follicle simulating hormone-granulosa cell axis involvement in the antifolliculotrophic effect of low dose mifepristone (RU486) Hum Reprod 10 1995 1987 1991
7. R. Kazem, I. Messinis, P. Fowler, N. Groome, P. Knight, A. Templeton Effect of mifepristone (RU486) on the pituitary response to gonadotropin releasing hormone in women Hum Reprod 11 1996 2585 2590
8. N. Groome, P. Illingworth, M. O'Brien, R. Pai, F. Rodger, J. Mather Measurement of dimeric inhibin B throughout the human menstrual cycle J Clin Endocrinol Metab 81 1996 1401 1405
9. C. Welt, Y. Pagan, P. Smith, K. Rado, J. Hall Control of follicle-stimulating hormone by estradiol and the inhibins critical role of estradiol at the hypothalamus during luteal-follicular transition J Clin Endocrinol Metab 88 2003 1766 1771
10. I. Messinis, M. Krishnan, R. Kazem, S. Khadilkar, A. Templeton Effect of mifepristone on folliculogenesis in women treated with recombinant FSH Clin Endocrinol 46 1997 309 314
11. I. Messinis, A. Templeton The effect of the antiprogestin mifepristone (RU 486) on maturation and in-vitro fertilization of human oocytes Br J Obstet Gynaecol 95 1988 592 595